Researcher Database

ICHIKAWA Nobuhiro

Department / Course College of Pharmaceutical Sciences Department of Pharmacy

Title / Position Professor

Papers
1.	2023/06	Evaluation of neurotoxicity of anticancer drugs using nematode Caenorhabditis elegans as a model organism. │ J. Toxicol. Sci. │ 48 (6),pp.311-321 (Co-authored)
2.	2023/01/13	Development of a useful single‑reference HPLC method for therapeutic drug monitoring of phenytoin and carbamazepine in human plasma │ Analytical Sciences │ 39,pp.01-08 (Co-authored)
3.	2022/12	Caffeine Content of Beverages. │ J. Food Sci. (kyoto Women's Univ.) │ ,pp.01-08 (Co-authored)
4.	2022/09	The effects on growth and reproductive function by parabens in C. elegans. │ Fundam. Toxicol. Sci. │ 9 (5),pp.145-150 (Co-authored)
5.	2022/07	Multigenerational effects of neonicotinoids (acetamiprid, clothianidin) on growth, fertility and motility of nematode C. elegans. │ Fundam. Toxicol. Sci. │ 9 (3),pp.95-102 (Co-authored)
6.	2022/08	Effects of chronic exposure of Caenorhabditis elegans to neonicotinoids (imidacloprid, dinotefuran) over multiple generations. │ Japanese Journal of Food Chemistry and Safety │ 29 (2),pp.1-8 (Co-authored)
7.	2022/06	Investigation ofDispensedMedicinesThatCanAffecttheRecognitionFunctionofElderlyPatientsat aCommunityPharmacyLocatedinaSatelliteCity. │ Jap. J. Soc. Pharm. │ ,pp.37-44 (Co-authored)
8.	2021/01	In vivo and in silico analyses of estrogenic potential of equine estrogens in medaka (Oryzias latipes). │ Sci. Total Environ. │ 767,pp.144379 (Co-authored)
9.	2020/03	Potential mechanisms underlying embryonic developmental toxicity caused by benzo[a]pyrene in Japanese medaka (Oryzias latipes) . │ Chemosphere │ 242,pp.125243 (Co-authored)
10.	2016/11	Gene expression analyses of vitellogenin, choriogenin, and estrogen receptor subtypes in the livers of male medaka (Oryzias latipes) exposed to equine estrogens. │ J. Appl. Toxicol. │ 36 (11),pp.1392-1400 (Co-authored)
11.	2018/04	Occurrence and seasonal variation of equine estrogens, equilin and equilenin, in the river water of Japan: implication with endocrine-disrupting potentials to Japanese medaka (Oryzias latipes) . │ Environmental Pollution │ 239,pp.281-288 (Co-authored)
12.	2014/05	The removing and discharge of the synthetic polycyclic musk compounds in sewage treatment plant. │ J. Environ. Safe. │ 5 (1),pp.27-34 (Co-authored)
13.	2013/06	Safe and effective delivery of small interfering RNA with polymer- and liposomes-based complexes. │ Biol. Pharm. Bull. │ 36 (6),pp.995-1001 (Co-authored)
14.	2013/02	Newly Diagnosis of Malignant Glioma by the Expression of Metallothionein isoforms. │ Memoirs of the Institute of Science and Engineering, Ritsumeikan University │ 71,pp.73-79 (Co-authored)
15.	2012/07	Susceptibility of Spore-forming butyric acid bacteria to Antimicrobial agents. │ Yakugaku Zasshi │ 132,pp.849-853 (Co-authored)
16.	2010/08	Contamination of pharmaceutical and personal care products in sewage treatment plants and surface waters in South Korea and their removal during activated sludge treatment. │ J. Environ. Chem. │ 20 (2),pp.127-135 (Co-authored)
17.	2009/04	Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes). │ J. Toxicol. Sci. │ 34 (2),pp.227-232 (Co-authored)
18.	2009/04	Occurrence of Pharmaceutical and Personal Care Products (PPCPs) in Surface Water from Mankyung River, South Korea. │ J.Health Sci. │ 55 (2),pp.249-258 (Co-authored)
19.	2008/08	Influence of murine hepatitis induced by D-(+)-galactosamine hydrochloride and lipopolysaccharide on gene expression of polyethylenimine/plasmid DNA polyplex. │ Biol. Pharm. Bull. │ 31,pp.1585-1589 (Co-authored)
20.	2008/07	Hybrid vector including polyethylenimine and cationic lipid, DOTMA, for gene delivery. │ Inter. J. Pharm. │ 363,pp.58-65 (Co-authored)
21.	2007/12	Electrophysiological Characterization of Tight Junctional Pathway of Rabbit Cornea Treated with Ophthalmic Ingredients. │ Biol. Pharm. Bull. │ 30,pp.2360-2364 (Co-authored)
22.	2006/11	Investigation for proper use of probiotics in Nagasaki University Hospital of Medicine and Dentistry. │ Yakugaku Zasshi │ 126,pp.1155-1161 (Co-authored)
23.	2006/10	Transport of timolol and tilisolol in rabbit corneal epithelium. │ Biol. Pharm. Bull. │ 29,pp.2143-2147 (Co-authored)
24.	2006/08	Partial Hepatectomy Enhances Polyethylenimine-Mediated Plasmid DNA Delivery. │ Biol.Pharm.Bull. │ 29,pp.1712-1716 (Co-authored)
25.	2006/07	PEGylated liposomes loading palmitoyl prednisolone for prolonged blood concentration of prednisolone. │ Biol. Pharm. Bull. │ 29,pp.1436-1440 (Co-authored)
26.	2006/05	Prolonged blood concentration of prednisolone after intravenous injection of liposomal palmitoyl prednisolone. │ J. Control Release │ 112,pp.320-328 (Co-authored)
27.	2006/04	Transport of acebutolol through rabbit corneal epithelium. │ Biol.Pharm.Bull. │ 29,pp.846-849 (Co-authored)
28.	2006/03	Influence of disease stage on polyethylenimine-mediated plasmid DNA delivery in murine hepatitis. │ Int. J. Pharmaceut. │ 318,pp.139-145 (Co-authored)
29.	2006/01	In vitro activity of lauric acid or myristylamine in combination with six antimicrobail agents against methikcillin-resistant Staphylococcus aureus (MRSA). │ Int. J. Antimicrob. Agents │ 27,pp.51-57 (Co-authored)
30.	2004/07	In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits. │ Int. J. Pharmaceut. │ 278,pp.255-262 (Co-authored)
31.	2003/05	One-side-coated insert as a unique ophthalmic drug delivery system. │ J. Control Release │ 92,pp.241-247 (Co-authored)
32.	1999/05	Distribution of ciprofloxacin into the central nervous system in rats with acute renal or hepatic failure. │ J. Pharm. Pharmacol. │ 51 (5),pp.609-616 (Co-authored)
33.	1996/09	Isolation and primary culture of rat cerebral microvascular endothelial cells for studying drug transport in vitro │ J. Pharmacol. Toxicol. Methods │ 36 (1),pp.45-52 (Co-authored)
34.	1996/04	Saturable transport of valproic acid in rat choroid plexus in vitro │ J. Pharm. Sci. │ 85 (4),pp.423-426 (Co-authored)
35.	1995/11	Effect of fenbufen on the penetration of quinolone antibiotics into cerebrospinal fluid. Comparative study with 5 quinolones │ Drugs │ 45 (Suppl 2),pp.349-351 (Co-authored)
36.	1994/11	Metabolic degradation of [6]-gingerol in rat jejunal mucosa │ Jpn. J. Hosp. Pharm. │ 20 (6),pp.530-536 (Co-authored)
37.	1994/02	Comparative Study of Permeability into Rat Cerebrospinal Fluid of the Quinolones : Dependency on Their Lipophilicities │ Biol. Pharm. Bull. │ 17 (1),pp.152-155 (Co-authored)
38.	1993/10	Comparative neurotoxicity study of ciprofloxacin and sparfloxacin after coadministration with fenbufen in rats │ Drugs │ 45 (Suppl.3),pp.290-997291 (Co-authored)
39.	1992/11	Effect of fenbufen on the entry of new quinolones, norfloxacin and ofloxacin, into the central nervous system in rats │ J. Pharm. Pharmacol. │ 44 (44),pp.915-920 (Co-authored)
40.	1991/09	Enhanced entry of ciprofloxacin into the rat central nervous system induced by fenbufen │ J. Pharmacol. Exp. Ther. │ 258 (3),pp.1033-1037 (Co-authored)
41.	1990/11	High-performance liquid chromatographic determination of ciprofloxacin in rat brain and cerebrospinal fluid │ Chem. Pharm. Bull. │ 38 (10),pp.2884-2886 (Co-authored)
42.	1990/10	A possible reduction in the renal clearance of ciprofloxacin by fenbufen in rats │ J. Pharm. Pharmacol. │ 42 (10),pp.704-707 (Co-authored)
43.	1990/08	Simultaneous high-performance liquid chromatographic determination of ciprofloxacin, fenbufen and felbinac in rat plasma │ J. Chromatogr. │ 530 (1),pp.186-191 (Co-authored)
44.	1990/04	A minor possibility of pharmacokinetic interaction between enoxacin and fenbufen in rats │ J. Pharmacobio-Dyn. │ 13 (2),pp.90-96 (Co-authored)
45.	1989/09	Simplified procedures for the simultaneous determination of enoxacin, fenbufen and felbinac in rat plasma by high-performance liquid chromatography │ 15 (4),pp.292-298 (Co-authored)
46.	1989/06	A possible reduction of ciprofloxacin clearance by fenbufen in rats │ Proceedings of the 16th International Congress of Chemotherapy │ ,pp.223.1-223.2 (Co-authored)
47.	1989/06	Absence of pharmacokinetic interaction between enoxacin or norfloxacin and fenbufen in rats │ Proceedings of the 16th International Congress of Chemotherapy │ ,pp.329.1-329.2 (Co-authored)
48.	1988/01/01	Simultaneous determination of ofloxacin, fenbufen and felbinac in rat plasma by high-performance liquid chromatography │ J. Chromatogr. │ 431 (1),pp.132-142 (Co-authored)
49.	1984/01	Activities of heme metabolizing enzymes in vitamin deficient rats │ J. Pharmacobio-Dyn. │ 7 (1),pp.73-73 (Co-authored)